Literature DB >> 30278933

Hepatorenal protection during renal ischemia by quercetin and remote ischemic perconditioning.

Firouzeh Gholampour1, Zahra Sadidi2.   

Abstract

BACKGROUND: Pathogenesis of renal ischemia/reperfusion injury (IRI) involves oxidative stress response in the kidney and remote organs. Both quercetin and remote ischemic perconditioning (RIPerC) can protect partially against IRI. This study determined whether combined quercetin and RIPerC could provide an augmented hepatorenal protection against renal IRI.
MATERIALS AND METHODS: I/R was induced by clamping renal arteries for 45 min followed by 24-h reperfusion. RIPerC consisted of four cycles of 2 min of left femoral artery ischemia followed by 3 min of reperfusion administered at the beginning of renal ischemia. Rats were divided into five groups: sham, I/R, RIPerC, quercetin (Q + I/R), and combined quercetin and RIPerC (Q + RIPerC). At the end of reperfusion period, blood, urine, and tissue samples were collected.
RESULTS: I/R caused kidney dysfunction, as proved by significant decrease in creatinine clearance, and a significant increase in liver functional indicators as evidenced by increased plasma alanine aminotransferase and aspartate aminotransferase activity. This was accompanied by a decrease of glutathione peroxidase and catalase activities with an increase of malondialdehyde levels and histological damages in renal and hepatic tissues. Treatment with RIPerC and quercetin reduced all these changes. However, the measure of improvements was enhanced by combined quercetin and RIPerC treatment.
CONCLUSIONS: This study demonstrated protective effects of quercetin and RIPerC strategy on the both kidney and liver after renal I/R. The results suggest that combined quercetin and RIPerC provides an enhanced protection against renal IRI by reduction of lipid peroxidation and augmentation of antioxidant systems.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Oxidative stress; Quercetin; Remote ischemic perconditioning; Reperfusion injury

Mesh:

Substances:

Year:  2018        PMID: 30278933     DOI: 10.1016/j.jss.2018.05.036

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  4 in total

1.  Treprostinil alleviates hepatic mitochondrial injury during rat renal ischemia-reperfusion injury.

Authors:  Joyce Hou; Evelyn Tolbert; Mark Birkenbach; Nisanne S Ghonem
Journal:  Biomed Pharmacother       Date:  2021-09-21       Impact factor: 6.529

Review 2.  Mechanistic Aspects and Therapeutic Potential of Quercetin against COVID-19-Associated Acute Kidney Injury.

Authors:  Lúcio Ricardo Leite Diniz; Marilia Trindade de Santana Souza; Allana Brunna Sucupira Duarte; Damião Pergentino de Sousa
Journal:  Molecules       Date:  2020-12-07       Impact factor: 4.411

Review 3.  Protective effect of quercetin on kidney diseases: From chemistry to herbal medicines.

Authors:  Yi-Qin Chen; Hao-Yin Chen; Qin-Qi Tang; Yi-Fan Li; Xu-Sheng Liu; Fu-Hua Lu; Yue-Yu Gu
Journal:  Front Pharmacol       Date:  2022-09-02       Impact factor: 5.988

4.  Preparation and evaluation of crocin loaded in nanoniosomes and their effects on ischemia-reperfusion injuries in rat kidney.

Authors:  Reyhaneh Naderi; Abbas Pardakhty; Mohammad Farajli Abbasi; Mehdi Ranjbar; Maryam Iranpour
Journal:  Sci Rep       Date:  2021-12-07       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.